血浆抗体技术专利申请现状及发展趋势分析

Analysis of Current Status and Development Trends of the Plasma Antibody Technology Patent Application

新冠肺炎的发生使得生物医药领域面临一次大考,但辩证来看对中国生物医药技术的发展也提供了一次机遇。本文介绍了康复期血浆抗体技术对于预防和治疗本次新冠肺炎的技术原理,并对该技术的相关专利情况,包括专利发展趋势、重要申请人、各国专利布局差异以及中国专利的地位和优劣势进行了分析,为血浆抗体技术的发展提供了相应的数据支撑,具有一定的参考意义。

The outbreak of the COVID-19 has put forward higher requirements for the field of biomedicine in China, but dialectically it also provides an opportunity for the development of biomedicine in China. Convalescence plasma antibody technology were introduced in this paper for the technology principle of the prevention and treatment of COVID-19, and related to the technology of the patent, including patent development trends and important applicants, the patent layout differences and China’s patent status and the advantages and disadvantages were analyzed. The above analysis provides the corresponding data support for the development of plasma antibody technology and has certain reference significance.